Retrovirology

official impact factor 5.24

This article is part of the supplement: 2005 International Meeting of The Institute of Human Virology

Open Access Poster presentation

The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1

Alonso Heredia*, Anthony Amoroso, Charles Davis, Nhut Le, Douty Bamba, Robert Gallo and Robert Redfield

  • * Corresponding author: Alonso Heredia

Retrovirology 2005, 2(Suppl 1):P134 doi:10.1186/1742-4690-2-S1-P134

No comments have yet been made on this article.

Post a comment